BackHemab Therapeutics Holdings Common Stock Overview

Hemab Therapeutics Holdings Common Stock Receivables

Track Hemab Therapeutics Holdings Common Stock's receivables ($1.4M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$1.43M

Peer average / median

Loading

Hemab Therapeutics Holdings Common Stock Receivables History

Loading

Hemab Therapeutics Holdings Common Stock vs. peers: Receivables Comparison

Loading

Hemab Therapeutics Holdings Common Stock Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Hemab Therapeutics Holdings Common Stock (COAG) FAQ

The latest receivables for COAG is $1.4M as of March 2026. Investors often review this figure alongside Hemab Therapeutics Holdings Common Stock's historical trend and sector peers before judging valuation or financial health.

A receivables figure of $1.4M for COAG is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting COAG's receivables ($1.4M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Hemab Therapeutics Holdings Common Stock's receivables against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.